SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000882104-20-000057
Filing Date
2020-05-05
Accepted
2020-05-04 18:20:29
Documents
8
Period of Report
2020-07-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A pdli-2020def14adoc.htm PRE 14A 1578307
2 a2020proxycard1.jpg GRAPHIC 158643
3 a2020proxycard2.jpg GRAPHIC 182881
4 a2020proxychart2.jpg GRAPHIC 34788
5 dmsignaturea01.jpg GRAPHIC 11435
6 gcsiga05.gif GRAPHIC 2504
7 pdllogoa32.jpg GRAPHIC 123123
8 totalstockholderreturna01.jpg GRAPHIC 47772
  Complete submission text file 0000882104-20-000057.txt   2331066
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-19756 | Film No.: 20846281
SIC: 2836 Biological Products, (No Diagnostic Substances)